Carolyn Rucci
General Counsel at AKEBIA THERAPEUTICS, INC.
Carolyn Rucci active positions
Companies | Position | Start | End |
---|---|---|---|
AKEBIA THERAPEUTICS, INC. | General Counsel | 2020-12-31 | - |
Career history of Carolyn Rucci
Former positions of Carolyn Rucci
Companies | Position | Start | End |
---|---|---|---|
AMAG PHARMACEUTICALS, INC. | General Counsel | 2015-12-31 | 2020-12-31 |
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
Training of Carolyn Rucci
Boston University School of Law | Graduate Degree |
Trinity College | Undergraduate Degree |
Statistics
International
United States | 5 |
Australia | 2 |
Operational
General Counsel | 2 |
Undergraduate Degree | 1 |
Graduate Degree | 1 |
Sectoral
Consumer Services | 3 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
AKEBIA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Wilmer Cutler Pickering Hale & Dorr LLP
Wilmer Cutler Pickering Hale & Dorr LLP Miscellaneous Commercial ServicesCommercial Services Wilmer Cutler Pickering Hale & Dorr LLP provides legal services. It specializes in trial, appellate, securities, regulatory, intellectual property, corporate transactions, bankruptcy, environmental, labor and employment, private client, real estate and tax matters. The company was founded in 1918 and is headquartered in Boston, MA. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Carolyn Rucci
- Experience